Realtor Credits New Immunotherapy for Destroying the Cancer That Threatened His Life
ESSA Pharma Inc. (EPIX)
Last essa pharma inc. earnings: 2/13 05:48 pm
Check Earnings Report
US:NASDAQ Investor Relations:
essapharma.com/investors
Company Research
Source: PR Newswire
LOS ANGELES, March 2, 2020 /PRNewswire/ -- A Virginia real estate broker wants to use his story of defeating cancer to help others facing the disease.Gary Gardiner Jr. battled cancer for 18 months, trying conventional and radical new therapies. Today, Gardiner and his wife, Teresa, are advocates for CAR T-cell therapy, a treatment in which a patient's own cells are genetically altered to attack the cancer.Families just like the Gardiners rely on companies researching and developing new treatments for cancers. Several leaders in this category are developing new and novel treatments that utilize breakthroughs now in testing including ESSA Pharma Inc. (NASDAQ: EPIX), Genocea Biosciences (NASDAQ: GNCA) and Synlogic, Inc. (NASDAQ: SYBX).Also blazing a trail is Oncolytics Biotech Inc., (NASDAQ: ONCY) (TSX: ONC), a development stage biotech company working on an immuno-oncology virus called pelareorep. Pelareorep is a safe and well-tolerated treatment that has the potential to bolster the po
Show less
Read more
Impact Snapshot
Event Time:
EPIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EPIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EPIX alerts
High impacting ESSA Pharma Inc. news events
Weekly update
A roundup of the hottest topics
EPIX
News
- When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit? [Yahoo! Finance]Yahoo! Finance
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Yahoo! Finance]Yahoo! Finance
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 [Yahoo! Finance]Yahoo! Finance
- ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024PR Newswire
EPIX
Earnings
- 5/14/24 - Miss
EPIX
Sec Filings
- 12/17/24 - Form 8-K
- 12/17/24 - Form 10-K
- 12/16/24 - Form 8-K
- EPIX's page on the SEC website